CellGenix is an internationally leading manufacturer and supplier of high quality products in the expanding markets of cell therapy and regenerative medicine.
The company was founded in 1994 and is located in Freiburg, Germany. CellGenix develops, manufactures and markets high quality GMP cell processing reagents like cytokines, serum-free media and closed kit systems. The company operates a state-of-the-art GMP facility for production of recombinant proteins and for cell processing.
CellGenix’s fully owned subsidiary Metreon Bioproducts GmbH provides GMP allogeneic cord blood stem cells and CartiGro® autologous chondrocytes to our cooperation partners.
With this unique background and the track record in clinical application CellGenix is ideally positioned to become
CellGenix continuously expands its comprehensive portfolio of serum-free media, cytokines and other cell culture supplements according to the needs of the growing cell therapy field.
Clinical cell therapy requires ancillary materials and tools which are GMP compliant.
CellGro® products are manufactured according to current GMP guidelines, considering our ADCF and serum-free policy. For many products , Drug Master Files have been filed at the FDA. USP chapter <1043> "ancillary materials for cell, gene and tissue-engineered products" is considered in the design of all CellGro® products. Conformance of IL-4 with the new USP chapter <92> standard supports our high quality claim.
CellGro® products combine a maximum of quality and safety with excellence performance due to state-of-the-art production, quality control and stringent documentation expertise.
CellGro® is a registered trade mark of CellGenix in several European countries and Japan. In the USA CellGro® reagents are marketed under CellGenixTM.
Am Flughafen 16
79108 Freiburg / Germany
Phone: +49 761 888 89-0
Fax: +49 761 888 89-830
One New Hampshire Avenue
Portsmouth, NH 03801 / USA
Phone: +1 603 373 0408
Fax: +1 603 373 8104